“Cellular Immunotherapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cellular immunotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for cellular immunotherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The cellular immunotherapy market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Scope
Markets Covered:
- 1) By Therapy: Tumor-Infiltrating Lymphocyte (TIL) Therapy; Engineered T Cell Receptor (TCR) Therapy; Chimeric Antigen Receptor (CAR) T Cell Therapy; Natural Killer (NK) Cell Therapy
- 2) By Primary Indication: B-cell Malignancies; Prostate Cancer; Renal Cell Carcinoma; Liver Cancer; Non-Hodgkin lymphoma; Other Primary Indications
- 3) By Application: Prostate Cancer; Breast Cancer; Skin Cancer; Ovarian Cancer; Brain Tumor; Lung Cancer; Other Applications
- Companies Mentioned: Novartis International AG; Gilead Sciences Inc.; Apac Biotech; Dendreon Pharmaceuticals LLC; JW CreaGene Co. Ltd
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Executive Summary
Cellular immunotherapy represents an innovative approach to immunotherapy where patients are administered T cells, a type of immune cell, to assist the body in combating diseases such as cancer. It harnesses the body's immune system to fight against cancer.
The key therapies within cellular immunotherapy include tumor-infiltrating lymphocyte (TIL) therapy, engineered T cell receptor (TCR) therapy, chimeric antigen receptor (CAR) T cell therapy, and natural killer (NK) cell therapy. Tumor-infiltrating lymphocyte (TIL) therapy is a form of adoptive cellular therapy involving the extraction of lymphocytes that have infiltrated tumors, their cultivation and amplification in vitro, and subsequent infusion into patients for therapeutic purposes. This therapy finds application in various primary indications, including b-cell malignancies, prostate cancer, renal cell carcinoma, liver cancer, non-Hodgkin lymphoma, among others, and is utilized in the treatment of conditions such as prostate cancer, breast cancer, skin cancer, ovarian cancer, brain tumors, lung cancer, and more.
The cellular immunotherapy market research report is one of a series of new reports from The Business Research Company that provides cellular immunotherapy market statistics, including cellular immunotherapy industry global market size, regional shares, competitors with a cellular immunotherapy market share, detailed cellular immunotherapy market segments, market trends and opportunities, and any further data you may need to thrive in the cellular immunotherapy industry. This cellular immunotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The cellular immunotherapy market size has grown rapidly in recent years. It will grow from $4.99 billion in 2023 to $5.78 billion in 2024 at a compound annual growth rate (CAGR) of 15.9%. The growth observed during the historical period can be attributed to advancements in cancer treatment, documented clinical success stories, regulatory approvals, and the increasing incidence of targeted diseases.
The cellular immunotherapy market size is expected to see rapid growth in the next few years. It will grow to $9.95 billion in 2028 at a compound annual growth rate (CAGR) of 14.6%. The anticipated growth in the forecast period can be attributed to the expansion of cellular immunotherapy into solid tumors, enhancements in manufacturing processes, the development of healthcare infrastructure, and increased research funding. Key trends expected in the forecast period encompass heightened investments in research and development, the availability of valuable clinical trial data, and the exploration of combination therapies.
The growth of the cellular immunotherapy market is being propelled by increasing research and successful clinical trials in the field. Companies are dedicated to developing new cellular immunotherapies to address various diseases. As of April 2022, there were 2,756 active cell therapy drugs globally, a 36% increase from 2021, indicating rapid growth in this sector. This growth, particularly in clinical and preclinical stages, is expected to expand the cellular immunotherapy landscape, driving market revenues higher.
The prevalence of cancer is another factor expected to drive the growth of the cellular immunotherapy market. Cancer is a group of diseases characterized by uncontrolled cell growth, spurring research and investment in cancer therapies, including cellular immunotherapies. These therapies leverage the patient's immune system to combat cancer cells, contributing to the rise of cellular immunotherapies. In 2021, the United States saw an estimated 1.9 million new cancer cases and 608,570 cancer-related deaths. This underscores the growing demand for effective cancer treatments, further boosting the cellular immunotherapy market.
The high cost of cellular immunotherapies poses a significant hindrance to market growth. CAR-T therapy, a type of cellular immunotherapy, is costly, with treatments like Yescarta and Kymriah priced over $350,000 per treatment in the USA. This cost is often unaffordable for many patients, especially those with lower incomes, leading to reduced demand and negatively impacting the market.
Companies in the cellular immunotherapy market are focusing on the development of off-the-shelf allogeneic therapies to improve cancer treatment. These therapies use donor cells rather than the patient's cells, offering benefits such as cost-effectiveness, large-scale production, speed, and quality control. Novartis, for example, received expedited FDA approval for Kymriah to treat adult patients with relapsed or refractory follicular lymphoma. Acepodia initiated a phase 1 clinical trial for ACE1702, an allogeneic, off-the-shelf NK cell therapy to treat solid tumors.
Major companies in the cellular immunotherapy market are also investing in innovative technologies like T-Charge to enhance their profitability. T-Charge, introduced by Novartis, maintains the critical properties of T cells, resulting in improved proliferative capacity, fewer exhausted T cells, and better treatment outcomes with reduced side effects.
In August 2021, BioNTech, a German biotechnology company, acquired Kite Pharma, a biotechnology company, to expand its immunotherapy pipeline. This acquisition provides BioNTech with Kite's laboratory and unique TCR platform, allowing the company to accelerate its immunotherapy research and development capabilities. Kite Pharma, based in the US, is known for developing cancer immunotherapy products.
Major companies operating in the cellular immunotherapy market include Novartis International AG, Gilead Sciences Inc., Apac Biotech, Dendreon Pharmaceuticals LLC, JW CreaGene Co. Ltd., Green Cross Corp, AstraZeneca PLC, Bristol Myers Squibb Company, Pfizer Inc., F. Hoffmann-La Roche Ltd., Adicet Bio Inc., ResTORbio Inc., Celyad SA, Merck KGaA, GlaxoSmithKline plc., Johnson & Johnson, Adaptimmune Therapeutics PLC, AVROBIO Inc., Cellular Biomedicine Group Inc., Kite Pharma Inc., Juno Therapeutics Inc., Celgene Corporation, Bluebird Bio Inc., Tmunity Therapeutics Inc., Atara Biotherapeutics Inc., Fate Therapeutics Inc., Precision Biosciences Inc., Allogene Therapeutics Inc., CRISPR Therapeutics AG, Sangamo Therapeutics Inc., Intellia Therapeutics Inc., Editas Medicine Inc., Caribou Biosciences Inc., Mammoth Biosciences Inc., Synthego Corporation
North America was the largest region in the cellular immunotherapy market in 2023. The regions covered in the cellular immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the cellular immunotherapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada
The cellular immunotherapy market includes revenues earned by entities by inventing, developing, administering, and understanding engineered immune effector cells. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Table of Contents
1. Executive Summary
2. Cellular Immunotherapy Market Characteristics
3. Cellular Immunotherapy Market Trends And Strategies
4. Cellular Immunotherapy Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Cellular Immunotherapy Market Size and Growth
- 5.1. Global Cellular Immunotherapy Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Cellular Immunotherapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Cellular Immunotherapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Cellular Immunotherapy Market Segmentation
- 6.1. Global Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Tumor-Infiltrating Lymphocyte (TIL) Therapy
- Engineered T Cell Receptor (TCR) Therapy
- Chimeric Antigen Receptor (CAR) T Cell Therapy
- Natural Killer (NK) Cell Therapy
- 6.2. Global Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- B-Cell Malignancies
- Prostate Cancer
- Renal Cell Carcinoma
- Liver Cancer
- Non-Hodgkin lymphoma
- Other Primary Indications
- 6.3. Global Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Prostate Cancer
- Breast Cancer
- Skin Cancer
- Ovarian Cancer
- Brain Tumor
- Lung Cancer
- Other Applications
7. Cellular Immunotherapy Market Regional And Country Analysis
- 7.1. Global Cellular Immunotherapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Cellular Immunotherapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Cellular Immunotherapy Market
- 8.1. Asia-Pacific Cellular Immunotherapy Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Cellular Immunotherapy Market
- 9.1. China Cellular Immunotherapy Market Overview
- 9.2. China Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Cellular Immunotherapy Market
- 10.1. India Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Cellular Immunotherapy Market
- 11.1. Japan Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.2. Japan Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Cellular Immunotherapy Market
- 12.1. Australia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Cellular Immunotherapy Market
- 13.1. Indonesia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Cellular Immunotherapy Market
- 14.1. South Korea Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.2. South Korea Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Cellular Immunotherapy Market
- 15.1. Western Europe Cellular Immunotherapy Market Overview
- 15.2. Western Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Cellular Immunotherapy Market
- 16.1. UK Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Cellular Immunotherapy Market
- 17.1. Germany Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Cellular Immunotherapy Market
- 18.5. France Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.6. France Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.7. France Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Cellular Immunotherapy Market
- 19.9. Italy Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.10. Italy Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.11. Italy Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Cellular Immunotherapy Market
- 20.13. Spain Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.14. Spain Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.15. Spain Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Cellular Immunotherapy Market
- 21.1. Eastern Europe Cellular Immunotherapy Market Overview
- 21.2. Eastern Europe Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Cellular Immunotherapy Market
- 22.1. Russia Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Cellular Immunotherapy Market
- 23.1. North America Cellular Immunotherapy Market Overview
- 23.2. North America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Cellular Immunotherapy Market
- 24.1. USA Cellular Immunotherapy Market Overview
- 24.2. USA Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Cellular Immunotherapy Market
- 25.1. Canada Cellular Immunotherapy Market Overview
- 25.2. Canada Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Cellular Immunotherapy Market
- 26.1. South America Cellular Immunotherapy Market Overview
- 26.2. South America Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Cellular Immunotherapy Market
- 27.1. Brazil Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Cellular Immunotherapy Market
- 28.1. Middle East Cellular Immunotherapy Market Overview
- 28.2. Middle East Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Cellular Immunotherapy Market
- 29.1. Africa Cellular Immunotherapy Market Overview
- 29.2. Africa Cellular Immunotherapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Cellular Immunotherapy Market, Segmentation By Primary Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Cellular Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Cellular Immunotherapy Market Competitive Landscape And Company Profiles
- 30.1. Cellular Immunotherapy Market Competitive Landscape
- 30.2. Cellular Immunotherapy Market Company Profiles
- 30.2.1. Novartis International AG
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Gilead Sciences Inc.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. Apac Biotech
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Dendreon Pharmaceuticals LLC
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. JW CreaGene Co. Ltd
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
31. Global Cellular Immunotherapy Market Competitive Benchmarking
32. Global Cellular Immunotherapy Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Cellular Immunotherapy Market
34. Cellular Immunotherapy Market Future Outlook and Potential Analysis
- 34.1 Cellular Immunotherapy Market In 2028 - Countries Offering Most New Opportunities
- 34.2 Cellular Immunotherapy Market In 2028 - Segments Offering Most New Opportunities
- 34.3 Cellular Immunotherapy Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies
35. Appendix
- 35.1. Abbreviations
- 35.2. Currencies
- 35.3. Historic And Forecast Inflation Rates
- 35.4. Research Inquiries
- 35.5. The Business Research Company
- 35.6. Copyright And Disclaimer
